首页 | 本学科首页   官方微博 | 高级检索  
     


Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation
Authors:W. Wang MD  J. Chen MD  Y.‐W. Yao MD  Y. Yan MD  S.‐S. Wu MD  X.‐X. Hu MD  L.‐H. Ke MD  J.‐Y. Niu MD  H.‐M. Li MD  C.‐S. Ji MD  B. Hu MD
Affiliation:1. Department of Medical Oncology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui, China;2. Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, Anhui, China
Abstract:Neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) had been analysed in many kind of tumours, but its role of predict the oesophageal squamous cell carcinoma (ESCC) patients’ prognosis was not reach a consensus. Relationship between NLR, PLR and ESCC located in the middle or lower segment was evaluated. 317 patients with ESCC who underwent attempted curative oesophagectomy were analysed in this study. 157 and 98 patients had elevated NLR and PLR respectively (NLR >3.3 and PLR >150). The median overall survival time (OS) and disease‐free survival (DFS) was 34.1 and 19.2 months respectively. Multivariate analysis found PLR >150 (P = 0.018, HR 1.426, 95%CI 1.063–1.912) accompanied by male, lymphatic metastases, tumour size more than 3 cm, tumour located at middle segment and poor differentiation were associated with significantly worse DFS. Meanwhile, gender, lymphatic metastases, tumour location and differentiation along with PLR >150 (P = 0.003, HR 1.595, 95% CI 1.172–2.170) and NLR>3.3 (P = 0.039, HR 1.367, 95% CI 1.015–1.840) were all independent prognostic factors for OS. Preoperative NLR and PLR might be used as predictive factors in patients with ESCC. For DFS, elevated PLR compared to NLR may have an advantage to indicate poor prognosis.
Keywords:   ESCC     neutrophil lymphocyte ratio  platelet lymphocyte ratio  overall survival  disease‐free survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号